(Q37393834)

20 August 2017

1 reference

title

IL-22: a critical mediator in mucosal host defense (English)

1 reference

20 August 2017

S J Aujla

1

1 reference

PubMed ID

19219418

20 August 2017

J K Kolls

series ordinal

2

1 reference

20 August 2017

14 February 2009

1 reference

Journal of Molecular Medicine

20 August 2017

1 reference

20 August 2017

87

1 reference

20 August 2017

5

1 reference

20 August 2017

451-454

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-009-0448-1

20 August 2017

0 references

cites work

Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-009-0448-1

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-009-0448-1

IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-009-0448-1

Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.

21 January 2018

1 reference

12 December 2020

IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration

1 reference

12 December 2020

IL-22 increases the innate immunity of tissues

1 reference

12 December 2020

IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation

1 reference

12 December 2020

T(H)-17 cells in the circle of immunity and autoimmunity

1 reference

12 December 2020

T(H)-17: a giant step from T(H)1 and T(H)2

1 reference

12 December 2020

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

1 reference

12 December 2020

RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells

1 reference

12 December 2020

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

1 reference

12 December 2020

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

12 December 2020

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

1 reference

12 December 2020

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

1 reference

12 December 2020

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

1 reference

12 December 2020

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

1 reference

12 December 2020

Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts

1 reference

12 December 2020

Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial

1 reference

12 December 2020

Interleukin-22: a potential immunomodulatory molecule in the lung.

1 reference

12 December 2020

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

12 December 2020

Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes.

1 reference

12 December 2020

10.1007/S00109-009-0448-1

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19219418